2022 ÇÏ°è ½ÉÀå»öÀü¿¬±¸È¸ ÇÁ·Î±×·¥ : 2022-08-20 |
|
2022 ÇÏ°è ½ÉÀå»öÀü¿¬±¸È¸ ÇÁ·Î±×·¥ : 2022-08-20 ±³À°ÀÏÀÚ : 2022-08-20 ±³À°Àå¼Ò : ´õÄÉÀÌÈ£ÅÚ ±³À°ÁÖÁ¦ : 2022 ÇÏ°è ½ÉÀå»öÀü¿¬±¸È¸ ÇÁ·Î±×·¥ ÁÖÃÖ±â°ü : ´ëÇѳúÁ¹ÁßÇÐȸ ½ÃÇà±â°ü(ÁöºÎ/°ú) : ½ÉÀå»öÀü¿¬±¸È¸ ´ã´çÀÚ : ±èÈñ¿µ ¿¬¶ôó : 0502-2277-1919 À̸ÞÀÏ : stroke@stroke.or.kr ±³À°Á¾·ù : ½Å°æ¿Ü°ú, ¿µ»óÀÇÇаú, ½Å°æ°ú, ÀçÈ°ÀÇÇаú Âü¼®¿¹»óÀοø : 100¸í Èñ¸ÁÆòÁ¡ : 3Á¡ Áö¿ª : ¼¿ïƯº°½Ã ±³À°½Ã°£ : 3 ½Ã°£ 55ºÐ ¼¼ºÎ¼ö°·á : 0¿ø ºñ°í ±¸ºÐ ¿ùÀÏ °ÀÇ½Ç ½Ã°£ ±³À°Á¦¸ñ °»ç¸í(¼Ò¼Ó) Çʼö°ú¸ñ ±âŸ 08-20 ´õÄÉÀÌÈ£ÅÚ 09:00~09:05 Àλ縻 ¼¿ì±Ù(½ÉÀå»öÀü¿¬±¸È¸ ȸÀå) ±³À°½Ã°£ 08-20 ´õÄÉÀÌÈ£ÅÚ 09:05~09:25 The role of NOAC in Post-TAVI management ±èÀº°æ(»ï¼º¼¿ïº´¿ø) ±³À°½Ã°£ 08-20 ´õÄÉÀÌÈ£ÅÚ 09:25~09:45 The selection of OAC in patients with CKD / HD ¼ÛÅÂÁø(À̴뼿ﺴ¿ø) ±³À°½Ã°£ 08-20 ´õÄÉÀÌÈ£ÅÚ 09:45~10:05 Expanding the indication in Neurology beyond A.fib stroke Á¤Á¾¿ø(»ï¼º¼¿ïº´¿ø) Åä·Ð 08-20 ´õÄÉÀÌÈ£ÅÚ 10:05~10:20 Panel discussion ÀÌ»óÈ, ÀÌ°ÇÁÖ, Á¤Çý¹®, È«±Ù½Ä, À¯¼º¿í(ÆгΠ: Ãáõ¼º½Éº´¿ø(ÀÌ»óÈ), °í·Á´ëÇб³ ±¸·Îº´¿ø(ÀÌ°ÇÁÖ), °æÈñ´ëÇб³º´¿ø(Á¤Çý¹®)/ÁÂÀå : ÀÎÁ¦´ëÀÏ»ê¹éº´¿ø(È«±Ù½Ä), °í´ë¾È¾Ïº´¿ø(À¯¼º¿í)) ÈÞ½Ä 08-20 ´õÄÉÀÌÈ£ÅÚ 10:20~10:40 Coffee break () ±³À°½Ã°£ 08-20 ´õÄÉÀÌÈ£ÅÚ 10:40~10:55 Anatomy and functional consideration of left atrial and appendage ½Å½Â¿ë(Á߾Ӵ뺴¿ø ¼øȯ±â³»°ú) ±³À°½Ã°£ 08-20 ´õÄÉÀÌÈ£ÅÚ 10:55~11:10 Diagnosis and concept of left atrium atriopathy ³ë½Â¿µ(°í·Á´ëÇб³ ±¸·Îº´¿ø ¼øȯ±â³»°ú) ±³À°½Ã°£ 08-20 ´õÄÉÀÌÈ£ÅÚ 11:10~11:25 Left atriopathy and risk of stroke ±èÁØ¿±(ºÐ´ç¼¿ï´ëÇб³º´¿ø) ±³À°½Ã°£ 08-20 ´õÄÉÀÌÈ£ÅÚ 11:25~11:40 Detecting paroxysmal AF with monitoring device in ESUS Á¤¿äÇÑ(°³²¼¼ºê¶õ½ºº´¿ø) Åä·Ð 08-20 ´õÄÉÀÌÈ£ÅÚ 11:40~12:00 Panel discussion À̹Îȯ, ±è¿µ¼, Á¶¹Î¼ö, ±èÁß¼±, ¼¿ì±Ù(ÆгΠ: ¼¿ï¼º¸ðº´¿ø(À̹Îȯ), ¿ø±¤´ëº´¿ø(±è¿µ¼), ¼¿ï¾Æ»êº´¿ø ¼øȯ±â³»°ú(Á¶¹Î¼ö)/ÁÂÀå : ¼¼ºê¶õ½ºº´¿ø(±èÁß¼±), »ï¼º¼¿ïº´¿ø(¼¿ì±Ù)) ½Ä»ç 08-20 ´õÄÉÀÌÈ£ÅÚ 12:00~13:00 Lunch () ±³À°½Ã°£ 08-20 ´õÄÉÀÌÈ£ÅÚ 13:00~13:20 Is CHADS2-VASC score the best? Any alternative? ±èÄ¡°æ(°í·Á´ëÇб³ ±¸·Îº´¿ø) ±³À°½Ã°£ 08-20 ´õÄÉÀÌÈ£ÅÚ 13:20~13:40 What should we consider for the risk of stroke recurrence in AF-stroke? (neurologist perspective) Àº¹Ì¿¬(°æºÏ´ëÇб³º´¿ø) ±³À°½Ã°£ 08-20 ´õÄÉÀÌÈ£ÅÚ 13:40~14:00 What should we consider for the risk of stroke recurrence in AF-stroke? (cardiologist perspective) ÀÌÁ¤¸í(°æÈñ´ëÇб³º´¿ø ¼øȯ±â³»°ú) Åä·Ð 08-20 ´õÄÉÀÌÈ£ÅÚ 14:00~14:20 Panel discussion ½ÅÁ¾¿í, ÀÌ»óÇå, ±èÁÖ¿¬, ¿Â¿µ±Ù, Ç㼺Çõ(ÆгΠ: ¼¼Á¾Ãæ³²´ëÇб³º´¿ø(½ÅÁ¾¿í), °í·Á´ëÇб³ ¾È»êº´¿ø(ÀÌ»óÇå), »ï¼º¼¿ïº´¿ø ¼øȯ±â³»°ú(±èÁÖ¿¬)/ ÁÂÀå : »ï¼º¼¿ïº´¿ø ¼øȯ±â³»°ú(¿Â¿µ±Ù), °æÈñ´ëº´¿ø(Ç㼺Çõ)) |
Tip. ±³À°ÀÏÁ¤Àº ±³À°±â°üÀÇ »çÁ¤¿¡ µû¶ó º¯°æµÉ ¼ö ÀÖÀ¸¹Ç·Î »çÀü¿¡ ¹Ýµå½Ã ±³À°±â°üÀ¸·Î ¹®ÀÇÇÏ¿© È®ÀÎ ¹Ù¶ø´Ï´Ù. |
|
Á¦¸ñ |
Ãßõ¼ö : 0 , Á¶È¸¼ö : 239 , ´ñ±Û¼ö : 0 |
Ãßõ¼ö : 0 , Á¶È¸¼ö : 137 , ´ñ±Û¼ö : 0 |
Ãßõ¼ö : 0 , Á¶È¸¼ö : 134 , ´ñ±Û¼ö : 0 |
Ãßõ¼ö : 0 , Á¶È¸¼ö : 134 , ´ñ±Û¼ö : 0 |
Ãßõ¼ö : 0 , Á¶È¸¼ö : 249 , ´ñ±Û¼ö : 0 |